<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Virology</title>
<title_fa>مجله ویروس شناسی ایران</title_fa>
<short_title>Iran J Virol</short_title>
<subject>Medical Sciences</subject>
<web_url>http://journal.isv.org.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>1735-5680</journal_id_issn>
<journal_id_issn_online>2588-5030</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.21859/isv</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1386</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2007</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>1</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Reovirus oncolysis: a brief insight on molecular mechanism and immunological aspect</title>
	<subject_fa>تخصصي</subject_fa>
	<subject>Special</subject>
	<content_type_fa>مروری</content_type_fa>
	<content_type>Review article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div&gt;
&lt;p&gt;&lt;strong&gt;Abstract :&lt;/strong&gt;&amp;nbsp; Reovirus (respiratory enteric orphan virus), a naturally occurring benign human pathogen, has an inherent ability to target transformed and cancerous cells and cause their lysis, while leaving non-transformed cells relatively unaffected.&amp;nbsp; The efficiency of this innate oncolytic activity of reovirus correlates with expression of the &lt;em&gt;ras&lt;/em&gt; oncogene.&amp;nbsp; Cells expressing activated Ras and the related Ras/RalGEF/p38 pathway are more permissive to the reovirus infection than that of untransformed counterparts.&amp;nbsp; &lt;em&gt;Ras&lt;/em&gt;-transformation orchestrates selective oncolysis of cancerous cells by mediating efficient virus uncoating as well as by enhancing infectivity and subsequent apoptosis-dependent release of nascent virus particles.&amp;nbsp; Different human and murine cell lines derived from naturally occurring tumors also display similar activation of the &lt;em&gt;ras&lt;/em&gt; pathway, and thus present selective susceptibility to reovirus oncolysis under &lt;em&gt;in vitro &lt;/em&gt;as well as&lt;em&gt; in vivo &lt;/em&gt;conditions.&amp;nbsp; This ability of reovirus to selectively target a wide variety of tumors offers a novel anti-cancer therapeutic option. However, the efficiency of reovirus virotherapy in immunocompetent hosts is compromised due to the presence of anti-viral innate and adaptive immune responses.&amp;nbsp; Hence, the success of this highly promising reovirus oncolytic therapy will likely be enhanced by modulating host immunity.&amp;nbsp;&lt;/p&gt;
&lt;/div&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>reovirus , cancer , virotherapy , oncolysis , ras oncogene</keyword>
	<start_page>1</start_page>
	<end_page>9</end_page>
	<web_url>http://journal.isv.org.ir/browse.php?a_code=A-10-43-23&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>S.A</first_name>
	<middle_name></middle_name>
	<last_name>Gujar </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846002385</code>
	<orcid>10031947532846002385</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Microbiology and Immunology, Dalhousie University Halifax, Nova Scotia, Canada</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>P.W.K</first_name>
	<middle_name></middle_name>
	<last_name>Lee </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Patrick.lee@dal.ca</email>
	<code>10031947532846002386</code>
	<orcid>10031947532846002386</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Microbiology and Immunology, Dalhousie University Halifax, Nova Scotia, Canada</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
